quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:01:34·1046d
NEWSRelease
Broadcom Inc. logo
BioNTech SE logo
Credit Suisse Group logo
+10

Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure: Today's Top Stories

AVGO· Broadcom Inc.BNTX· BioNTech SECS· Credit Suisse GroupGTLS· Chart Industries Inc.ILMN· Illumina Inc.IR· Ingersoll Rand Inc.
TechnologyHealth CareFinance
Original source

Companies

  • AVGO
    Broadcom Inc.
    Technology
  • BNTX
    BioNTech SE
    Health Care
  • CS
    Credit Suisse Group
    Finance
  • GTLS
    Chart Industries Inc.
    Industrials
  • ILMN
    Illumina Inc.
    Health Care
  • IR
    Ingersoll Rand Inc.
    Industrials
  • KDNY
    Chinook Therapeutics Inc.
    Health Care
  • NDAQ
    Nasdaq Inc.
    Finance
  • NVO
    Novo Nordisk A/S
    Health Care
  • NVS
    Novartis AG
    Health Care
  • RYAAY
    Ryanair Holdings plc
    Consumer Discretionary
  • UBS
    UBS Group AG Registered
    Finance
  • VMW
    Vmware Inc.
    Technology

Recent analyst ratings

  • Apr 20UBSUpdateBarclays-
  • Apr 13RYAAYUpdateBernstein-
  • Apr 8NDAQUpdateKeefe Bruyette$92.00
  • Apr 8AVGOUpdateSeaport Research Partners-
  • Apr 3AVGOUpdateErste Group-
  • Apr 2AVGOUpdateErste Group-

Related

  • INSIDER7h
    Director Samueli Henry was granted 864 shares, increasing direct ownership by 25% to 4,356 units (SEC Form 4)
  • PR7h
    Ingersoll Rand Declares Regular Quarterly Cash Dividend
  • INSIDER7h
    Chief Operating Officer Poetting Sierk sold $5,527,960 worth of Ordinary Shares (50,000 units at $110.56) (SEC Form 4)
  • SEC16h
    Nasdaq Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure
  • PR16h
    Nasdaq Announces Increase in Quarterly Dividend to $0.31 Per Share
  • PR16h
    Nasdaq Reports First Quarter 2026 Results; Strong Execution Drives Double-Digit Net Revenue Growth Across All Divisions
  • PR17h
    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
  • INSIDER1d
    SEC Form 4 filed by You Harry L.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022